🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Carcinoma

Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma NCT06342167Phase 210 sites📍 Beijing📍 Fujian📍 Handan Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Radiotherapy, Programmed Cell Death Protein 1 Inhibitor, Immunonutrition support Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound NCT07357571n/a2 sites📍 Guangdong📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University "Xijiang Project" Screening Cohort for NPC NCT06787456n/a1 site📍 Zhuhai Ming-Yuan Chen · Tests: EBV antibodies test, EBV DNA test, epidemiological information survey, Clinical examinations for high-risk participants… Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma NCT04448522Phase 36 sites📍 Guangzhou📍 Guangzhou📍 Shaoguan Sun Yat-sen University · Tests: reduced dosage IMRT, conventional dosage IMRT Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer NCT07070011n/a1 site📍 Shanghai Shanghai Chest Hospital of Shanghai Jiao Tong University · Tests: EC/EP + ICIs Breast Cancer Survivorship Biorepository NCT05786664n/a1 site📍 Los Angeles University of Southern California · Tests: Biospecimen Collection, Electronic Health Record Review, Quality-of-Life Assessment, Survey Administration Use of Magtrace Bracketing for Excision of Lesion and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast Cancer NCT07844473NA1 site📍 Madinah King Faisal Specialist Hospital & Research Center · Tests: Super paramagnetic iron oxide bracketing injection Manipulating E-Cigarette Nicotine to Promote Public Health NCT06448351NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Carbon Monoxide Measurement, Vaping session, Survey Administration Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCC NCT06876753n/a2 sites📍 Nanjing📍 Nanjing Zhongda Hospital Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation NCT06718153NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Immunohistochemistry and in situ hybridisation analysis Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix NCT04723095n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Follow-Up, Medical Chart Review Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer NCT06039644NA1 site📍 Taipei GenMont Biotech Incorporation · Tests: Probiotic, Placebo Adaptive Stereotactic Radiotherapy for Localized Prostate Cancer NCT07344844NA1 site📍 Saint-Denis Clinique Sainte Clotilde · Tests: Low-dose CT imaging before each SBRT session Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC) NCT07190755NA2 sites📍 Rouen📍 Vandœuvre-lès-Nancy Centre Henri Becquerel · Tests: Remote symptoms moniotring Shared Decision Making in Patients With Lung Cancer NCT05191485n/a1 site📍 Chengdu Sichuan Cancer Hospital and Research Institute · Tests: Qualitative interviews Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer NCT05998135Phase 21 site📍 Atlanta Emory University · Tests: Atovaquone, Biopsy, Computed Tomography, Paracentesis A Real World Study of Ensartinib in Advanced ALK-positive NSCLC NCT05498064n/a1 site📍 Beijing Peking Union Medical College Hospital · Tests: Ensartinib Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation NCT05010109NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: 6 Minute Walk Functional Test, Biospecimen Collection, Computed Tomography, Echocardiography, Exercise Cardiac Stress T… A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC NCT06424899Phase 21 site📍 Hangzhou Zeng Jian · Tests: Adebrelimab, radical chemoradiotherapy, Platinum based chemotherapy FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma NCT07012798Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Durvalumab, Bevacizumab, HAIC of FOLFOX Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung) NCT07120698Phase 22 sites📍 Guangzhou📍 Chengdu Guangdong Association of Clinical Trials · Tests: Sintilimab Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas NCT04620187Phase 213 sites📍 Atlanta📍 Chicago📍 Boston Dana-Farber Cancer Institute · Tests: Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy, Standard of Care Chemotherapy Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC NCT06162221Phase 1, Phase 298 sites📍 Gilbert📍 Duarte📍 Irvine Revolution Medicines, Inc. · Tests: RMC-6291, RMC-6236, Pembrolizumab, Cisplatin, Carboplatin Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites📍 Los Angeles📍 New Haven📍 New Haven Pfizer · Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study NCT07640048n/a1 site📍 Beijing Peking Union Medical College Hospital · Tests: Adebrelimab, Gemcitabine, Cisplatin, S-1, Apatinib A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors NCT06936735Phase 11 site📍 Shanghai Hansoh BioMedical R&D Company · Tests: HS-20108 Monotherapy Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors NCT06107608NA1 site📍 Brussels Jules Bordet Institute · Tests: FAPI PET/CT TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients NCT06455917Phase 21 site📍 Basel University Hospital, Basel, Switzerland · Tests: TILs（Tumor Infiltrating Lymphocytes） Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer NCT04913064NA1 site📍 Duarte City of Hope Medical Center · Tests: Questionnaire Administration, White Button Mushroom Extract
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy